The Enterprise Value as of October 2024 (TTM) for Kintara Therapeutics, Inc. (KTRA) is 7.08M

According to Kintara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.08M. This represents a change of -90.54% compared to the average of 74.82M of the last 4 quarters.

Kintara Therapeutics, Inc. (KTRA) Historical Enterprise Value (quarterly & annually)

How has KTRA Enterprise Value performed in the past?

The mean historical Enterprise Value of Kintara Therapeutics, Inc. over the last ten years is 843.21M. The current 7.08M Enterprise Value has changed -16.03% with respect to the historical average. Over the past ten years (40 quarters), KTRA's Enterprise Value was at its highest in in the June 2016 quarter at 3.04B. The Enterprise Value was at its lowest in in the March 2024 quarter at 8.93M.

Kintara Therapeutics, Inc. (KTRA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kintara Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kintara Therapeutics, Inc. (KTRA) Average Enterprise Value

How has KTRA Enterprise Value performed in the past?

The current Enterprise Value of Kintara Therapeutics, Inc. (KTRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kintara Therapeutics, Inc. (KTRA) Enterprise Value vs. Peers

How is KTRA’s Enterprise Value compared to its peers?

Kintara Therapeutics, Inc.’s Enterprise Value is greater than Fresh Tracks Therapeutics, Inc. (-6447751.00), less than SAB Biotherapeutics, Inc. (26.49M), greater than Theriva Biologics, Inc. (-10104457.00), greater than Lisata Therapeutics, Inc. (-4109555.00), less than Dyadic International, Inc. (30.09M), greater than Forte Biosciences, Inc. (-3253507.00), less than DiaMedica Therapeutics Inc. (173.56M), greater than Kineta, Inc. (6.78M), less than Longboard Pharmaceuticals, Inc. (2.31B), less than Lumos Pharma, Inc. (25.72M), less than ImmunoCellular Therapeutics, Ltd. (10.21M), less than Cellectar Biosciences, Inc. (57.01M), less than Bolt Biotherapeutics, Inc. (38.21M), less than First Wave BioPharma, Inc. (9.55M), greater than Salarius Pharmaceuticals, Inc. (-1168874.00), less than Vaccinex, Inc. (8.95M), less than GeoVax Labs, Inc. (13.96M), less than scPharmaceuticals Inc. (204.48M), less than Milestone Pharmaceuticals Inc. (118.30M), less than Oncolytics Biotech Inc. (100.80M), less than Seres Therapeutics, Inc. (280.43M), less than aTyr Pharma, Inc. (138.44M),

Build a custom stock screener for Kintara Therapeutics, Inc. (KTRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kintara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kintara Therapeutics, Inc. (KTRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kintara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.